Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence  Clinical Pharmacology and Therapeutics. 2025;117(4):927-937
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39807817

"Blanket rules just don't work": Qualitative exploration of the relative value of child and adult Quality Adjusted Life Year (QALY) gains for health technology assessment  International Journal of Technology Assessment in Health Care. 2025:1-34
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40151870

CAR-T cell therapies: patient access and affordability solutions  Future Sci OA. 2025;11(1):2483613
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40156283

A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049328

Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review  Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40049329

Enhancing systematic literature reviews with generative artificial intelligence: development, applications, and performance evaluation  Journal of the American Medical Informatics Association. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40036547

Guidance for an Effective Approach to Integrated Evidence Planning in a Dynamic World  Clinical Pharmacology and Therapeutics. 2025;117(4):920-926
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39789863

Harmonizing HTA Evidence Needs and Expectations: Challenges and Opportunities to Improve Evidence Generation, Ensure Access and Affordability  Clinical Pharmacology and Therapeutics. 2025;117(4):938-945
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39972486

Harnessing health technology assessment in India: paving the way for sustainable healthcare solutions in developing countries  BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40037703

Hospital admissions attributable to reduced air pollution due to clean-air policies in China  Nature Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40087514

Is health technology assessment value for money? Estimating the return on investment of health technology assessment in India (HTAIn)  BMJ Evidence Based Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40113231

Methods for the health technology assessment of complex interventions: A scoping review  PloS One. 2025;20(3):e0315381
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40085544

Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives  Arch Public Health. 2025;83(1):83
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40148921

NAVIGATING CHANGE: A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENT REFORMS ACROSS AGENCIES - PROCESSES, DRIVERS, AND INTERDEPENDENCIES  International Journal of Technology Assessment in Health Care. 2025:1-30
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40083319

New IPECAD Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer's Disease Treatment: Development and Use Cases  Value in Health. 2025;28(4):511-518
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39094686

PATIENT ENGAGEMENT FOR THE DEVELOPMENT OF EQUITY-FOCUSED HEALTH TECHNOLOGY ASSESSMENT (HTA) RECOMMENDATIONS: A CASE STUDY OF TWO CANADIAN HTA ORGANIZATIONS  International Journal of Technology Assessment in Health Care. 2025:1-28
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40151855

Planning Post-Launch Evidence Generation: Lessons From France, England and Spain  Clinical Pharmacology and Therapeutics. 2025;117(4):961-966
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39960266

The potential of the hospital-based Health Technology Assessment: Results of a world-wide survey  International Journal of Technology Assessment in Health Care. 2025;41(1):e19
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40099540

PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods  BMJ. 2025;388:e082505
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40127903

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18  Journal of Comparative Effectiveness Research. 2025;14(4):e250014
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39963965

Role of Health Equity in Health Technology Assessment Processes: A Landscape Analysis of 13 Health Systems in Asia  Value in Health. 2025;28(4):582-590
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39922297

Selection of indirect treatment comparisons for health technology assessments: a practical guide for health economics and outcomes research scientists and clinicians  BMJ Open. 2025;15(3):e091961
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40132816

Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective Pharmacoeconomics. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40117115

Use of Real-World Evidence in Health Technology Reassessments Across Six Health Technology Assessment Agencies  Value in Health. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40054770

Using natural experiments to evaluate population health and health system interventions: new framework for producers and users of evidence  BMJ. 2025;388:e080505
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40154983